MAZZINI, LETIZIA
 Distribuzione geografica
Continente #
EU - Europa 2.230
NA - Nord America 1.455
AS - Asia 424
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
OC - Oceania 1
Totale 4.124
Nazione #
US - Stati Uniti d'America 1.442
IE - Irlanda 753
IT - Italia 426
SE - Svezia 308
DE - Germania 291
UA - Ucraina 172
SG - Singapore 157
CN - Cina 104
FI - Finlandia 102
HK - Hong Kong 88
GB - Regno Unito 35
FR - Francia 34
CZ - Repubblica Ceca 29
NL - Olanda 26
IN - India 24
IR - Iran 21
BE - Belgio 18
TR - Turchia 14
PL - Polonia 13
CA - Canada 12
BR - Brasile 8
RO - Romania 8
JP - Giappone 7
CH - Svizzera 4
ES - Italia 4
EU - Europa 3
JO - Giordania 2
RS - Serbia 2
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
CL - Cile 1
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NG - Nigeria 1
PA - Panama 1
PH - Filippine 1
RU - Federazione Russa 1
TH - Thailandia 1
Totale 4.124
Città #
Dublin 749
Jacksonville 316
Dearborn 138
Chandler 113
Singapore 103
Hong Kong 86
Lawrence 66
Princeton 66
Wilmington 65
Piemonte 59
Beijing 47
San Mateo 47
Ann Arbor 46
Bremen 43
Boardman 35
Turin 34
Mülheim 28
Munich 26
Brno 24
Helsinki 24
Ashburn 22
Milan 21
Dallas 18
Strasbourg 18
Andover 16
Houston 16
Novara 14
Monmouth Junction 13
Rome 13
Woodbridge 13
Brussels 12
Nanjing 12
Zanjan 12
Vercelli 11
Kocmyrzów 9
Frankfurt am Main 8
Kocaeli 8
Kunming 8
Leawood 8
Amsterdam 7
Borgomanero 7
Toronto 7
Cassano Magnago 6
Falls Church 6
Norwalk 6
Seattle 6
Waanrode 6
Ardabil 5
Düsseldorf 5
Hefei 5
Radauti 5
Sacramento 5
Sannomaru 5
Santa Clara 5
São Paulo 5
Cologne 4
Espoo 4
Menlo Park 4
Trieste 4
Winchester 4
Zurich 4
Auburn Hills 3
Augusta 3
Brescia 3
Fairfield 3
Foglizzo 3
Gainesville 3
Guangzhou 3
Guarulhos 3
Nanchang 3
Pavia 3
Prague 3
Rimini 3
Stanmore 3
Alanís 2
Almere Stad 2
Amman 2
Ankara 2
Barcelona 2
Belgrade 2
Bologna 2
Cattolica 2
Changsha 2
Concordia sulla Secchia 2
Erding 2
Flushing 2
Honolulu 2
Jinan 2
Lissone 2
Lodi 2
London 2
Monza 2
New York 2
Odalengo Grande 2
Orbetello 2
Palermo 2
Pardubice 2
Phoenix 2
Portland 2
Rozzano 2
Totale 2.573
Nome #
Acetyl-L-carnitine and Amyotrophic Lateral Sclerosis: current evidence and potential use. 139
Human neural stem cell transplantation in ALS: initial results from a phase I trial. 95
Analysis of the GCG Repeat Length in NIPA1 Gene in C9orf72-mediated ALS in a Large Italian ALS Cohort 84
Advances in stem cell therapy for amyotrophic lateral sclerosis 83
Extensive genetics of ALS: a population-based study in Italy. 82
Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis 79
Coeliac disease mimicking Amyotrophic Lateral Sclerosis. 79
ALS Phenotype Is Influenced by Age, Sex, and Genetics: A Population-Based Study 76
A case of late-onset OCD developing PLS and FTD 70
Association of a locus in the CAMTA1 gene with survival in patients with sporadic amyotrophic lateral sclerosis 69
ATXN2 polyQ intermediate repeats are a modifier of ALS survival. 69
Amyotrophic Lateral Sclerosis Outcome Measures and the Role of Albumin and Creatinine: A Population-Based Study. 68
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 68
Characterization of the c9orf72 GC-rich low complexity sequence in two cohorts of Italian and Turkish ALS cases 68
A case of Progressive Non-Fluent Aphasia as onset of Amyotrophic Lateral Sclerosis with FrontoTemporal Dementia 67
Chitotriosidase and lysosomal enzymes as potential biomarkers of disease progression in amyotrophic lateral sclerosis: a survey clinic-based study. 66
Transplantation of mesenchymal stem cells in ALS. 65
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways 62
Ptosis and bulbar onset: an unusual phenotype of familial ALS? 61
The multistep hypothesis of ALS revisited: The role of genetic mutations 61
A novel peripherin gene (PRPH) mutation identified in one sporadic amyotrophic lateral sclerosis patient 59
Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival study 59
ATXN-2 CAG repeat expansions are interrupted in ALS patients 58
Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis 57
C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect. 57
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 56
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. 56
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 55
The First Case of the TARDBP p.G294V Mutation in a Homozygous State: Is a Single Pathogenic Allele Sufficient to Cause ALS? 55
Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials? 55
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial 54
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis 54
Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series 50
TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations 47
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia 47
A rare case of conjugal amyotrophic lateral sclerosis. 47
Cognitive impairment across ALS clinical stages in a population-based cohort 47
Detection of white matter ultrastructural changes for amyotrophic lateral sclerosis characterization: A diagnostic study from DTI-derived data 47
Mutational analysis of VCP gene in familial amyotrophic lateral sclerosis 46
SOD1 gene mutations in Italian patients with Sporadic Amyotrophic Lateral Sclerosis (ALS) 46
Functional status and oral health in patients with amyotrophic lateral sclerosis: A cross-sectional study 45
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis 45
A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis 44
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 44
Study protocol on the safety and feasibility of a normocaloric ketogenic diet in people with amyotrophic lateral sclerosis 43
Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia. 41
Non-invasive ventilation after surgery in amyotrophic lateral sclerosis 40
High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis 40
Mutations of FUS gene in sporadic amyotrophic lateral sclerosis 40
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: A population-based study 40
The Potential Role of Peripheral Oxidative Stress on the Neurovascular Unit in Amyotrophic Lateral Sclerosis Pathogenesis: A Preliminary Report from Human and In Vitro Evaluations 40
The prevention of falls in patients with Parkinson's disease with in-home monitoring using a wearable system: a pilot study protocol 39
Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study 39
Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a phase I clinical trial 39
Variations in the coding and regulatory sequences of the angiogenin (ANG) gene are not associated to ALS (amyotrophic lateral sclerosis) in the Italian population 39
MRI imaging and clinical features of sciatic nerve injection injury 38
Stem cells therapy for ALS 38
Ubiquilin 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia. 38
No association of DPP6 with amyotrophic lateral sclerosis in an Italian population 37
VPS54 genetic analysis in ALS Italian cohort 37
Neurological emergency at the COVID-19 pandemic: report from a referral hospital in Eastern Piedmont, Italy 37
The Role of Tau beyond Alzheimer’s Disease: A Narrative Review 37
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis 36
Telehealth in neurodegenerative diseases: Opportunities and challenges for patients and physicians 36
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study 35
Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS 34
Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression 34
Telehealth Approach For Amyotrophic Lateral Sclerosis Patients: The experience during COVID-19 pandemic 33
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants 29
Accelerated early progression of amyotrophic lateral sclerosis over the covid-19 pandemic 28
Adopting Assistive Technologies in Healthcare Processes: A Chatbot for Patients with Amyotrophic Lateral Sclerosis 27
Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers 25
Critical illness neuro-myopathy (CINM) and focal amyotrophy in intensive care unit (ICU) patients with SARS-CoV-2: a case series 23
Exploring the phenotype of Italian patients with ALS with intermediate ATXN2 polyQ repeats 23
Metal(loid)s role in the pathogenesis of amyotrophic lateral sclerosis: Environmental, epidemiological, and genetic data 22
Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study 22
A Telehealth Intervention for Nutritional Counseling in Amyotrophic Lateral Sclerosis Patients 22
Clinical and Metabolic Signature of UNC13A rs12608932 Variant in Amyotrophic Lateral Sclerosis 21
The Need for Biomarkers in the ALS-FTD Spectrum: A Clinical Point of View on the Role of Proteomics 19
Gastrointestinal Status and Microbiota Shaping in Amyotrophic Lateral Sclerosis: A New Frontier for Targeting? 19
Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses 18
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact 18
Plateaus in amyotrophic lateral sclerosis progression: results from a population-based cohort 17
Generation of an induced pluripotent stem cell line, CSSi011-A (6534), from an Amyotrophic lateral sclerosis patient with heterozygous L145F mutation in SOD1 gene 17
Respiratory support in a population-based ALS cohort: Demographic, timing and survival determinants 15
Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regions 15
New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer's Disease: Preventive and Therapeutic Perspectives 15
Exposure to electromagnetic fields does not modify neither the age of onset nor the disease progression in ALS patients 15
Mutational Analysis of Known ALS Genes in an Italian Population-Based Cohort 15
null 15
Potential role of vitamin D levels in amyotrophic lateral sclerosis cognitive impairment 15
Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis 14
What is amyotrophic lateral sclerosis prevalence? 14
Shotgun Proteomics Links Proteoglycan-4+ Extracellular Vesicles to Cognitive Protection in Amyotrophic Lateral Sclerosis 13
Reply to: Amyotrophic lateral sclerosis with depression, cognitive impairment, and mortality 13
Do ecological factors influence the clinical presentation of amyotrophic lateral sclerosis? 13
Tailoring patients' enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffs 13
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial) 13
Factors predicting disease progression in C9ORF72 ALS patients 12
Cell therapy in ALS: An update on preclinical and clinical studies 11
Totale 4.222
Categoria #
all - tutte 28.084
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.084


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020506 0 0 0 0 88 90 114 25 65 54 67 3
2020/2021445 55 2 55 2 55 13 86 18 70 13 68 8
2021/2022562 32 8 54 67 27 10 18 13 43 17 149 124
2022/20231.502 77 74 55 24 103 107 47 66 819 18 79 33
2023/2024602 55 36 75 33 91 20 89 8 10 7 54 124
2024/2025255 41 42 113 44 15 0 0 0 0 0 0 0
Totale 4.315